Telefon:: +49 (0)241 95 163 153
Fax:: +49 (0)241 95 163 155
E-Mail:: orders@antikoerper-online.de

Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.

Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) (N-Term) Peptid

SPG20 Reaktivität: Human Wirt: Synthetic BP, WB

Produktnummer ABIN5673676

150,78 €

Zzgl. Versandkosten 20,00 € und MwSt

100 μg

Lieferung nach: Deutschland

Lieferung in 15 bis 22 Werktagen

Kurzübersicht für Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) (N-Term) Peptid (ABIN5673676)

Target

SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))

Spezies

Human

Quelle

Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)

Protein Region

N-Term

Sequenz

MEQEPQNGEP AEIKIIREAY KKAFLFVNKG LNTDELGQKE EAKNYYKQGI

Produktmerkmale

This is a synthetic peptide designed for use in combination with anti- SPG20 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) peptide
SPG20 Reaktivität: Säugetier Wirt: Synthetic BP, WB, IHC

Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) peptide
SPG20 Wirt: Synthetic BP, Imm

Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) (Middle Region) peptide
SPG20 Reaktivität: Human Wirt: Synthetic BP, WB

Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) (Internal Region) peptide
SPG20 Reaktivität: Human Wirt: Synthetic BP, BI

Applikationshinweise

Optimal working dilution should be determined by the investigator.

Beschränkungen

Nur für Forschungszwecke einsetzbar
Format

Lyophilized

Rekonstitution

Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

Lagerung

-20 °C

Informationen zur Lagerung

For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target

SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))

Hintergrund

This gene encodes a protein containing a MIT (Microtubule Interacting and Trafficking molecule) domain, and is implicated in regulating endosomal trafficking and mitochondria function. The protein localizes to mitochondria and partially co-localizes with microtubules. Stimulation with epidermal growth factor (EGF) results in protein translocation to the plasma membrane, and the protein functions in the degradation and intracellular trafficking of EGF receptor. Multiple alternatively spliced variants, encoding the same protein, have been identified. Mutations associated with this gene cause autosomal recessive spastic paraplegia 20 (Troyer syndrome).

Alias Symbols: SPARTIN, TAHCCP1

Protein Size: 666

Gen-ID

23111

NCBI Accession

NM_001142294, NP_001135766

UniProt

Q8N0X7

Sie sind hier: